Skip to content
10-Q

Quarterly Report

Mirum Pharmaceuticals, Inc. MIRM

0001759425-25-000041

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 50.24M sh
Shares Diluted Q2 2025 · Jun 30, 2025 49.73M sh
Shares Diluted Q2 2025 · Jun 30, 2025 49.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 47.24M sh
Shares Diluted Q2 2025 · Jun 30, 2024 47.08M sh
Capex Q2 2025 · Jun 30, 2025 $167K
Capex Q2 2025 · Jun 30, 2024 $792K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $10.08M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $11.41M
Short Term Investments Q2 2025 · Jun 30, 2025 $76.43M
Short Term Investments Q2 2025 · Dec 31, 2024 $57.81M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $228.12M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $222.5M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $233.25M
Stockholders Equity Q2 2025 · Jun 30, 2025 $255.16M
Stockholders Equity Q2 2025 · Mar 31, 2025 $233.26M
Stockholders Equity Q2 2025 · Dec 31, 2024 $225.64M
Stockholders Equity Q2 2025 · Jun 30, 2024 $228.99M
Stockholders Equity Q2 2025 · Mar 31, 2024 $234.6M
Stockholders Equity Q2 2025 · Dec 31, 2023 $248.67M
Current Liabilities Q2 2025 · Jun 30, 2025 $144.8M
Current Liabilities Q2 2025 · Dec 31, 2024 $126.55M
Total Liabilities Q2 2025 · Jun 30, 2025 $470.67M
Total Liabilities Q2 2025 · Dec 31, 2024 $445.11M
Current Assets Q2 2025 · Jun 30, 2025 $453.4M
Current Assets Q2 2025 · Dec 31, 2024 $392.79M
Total Assets Q2 2025 · Jun 30, 2025 $725.83M
Total Assets Q2 2025 · Dec 31, 2024 $670.75M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.12
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.42
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.52
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.06
Eps Basic Q2 2025 · Jun 30, 2025 −$0.12
Eps Basic Q2 2025 · Jun 30, 2025 −$0.42
Eps Basic Q2 2025 · Jun 30, 2024 −$0.52
Eps Basic Q2 2025 · Jun 30, 2024 −$1.06
Sga Expense Q2 2025 · Jun 30, 2025 $63.29M
Sga Expense Q2 2025 · Jun 30, 2025 $120.99M
Sga Expense Q2 2025 · Jun 30, 2024 $49.21M
Sga Expense Q2 2025 · Jun 30, 2024 $94.85M
Net Income Q2 2025 · Jun 30, 2025 −$5.86M
Net Income Q2 2025 · Jun 30, 2025 −$20.54M
Net Income Q2 2025 · Mar 31, 2025 −$14.68M
Net Income Q2 2025 · Jun 30, 2024 −$24.64M
Net Income Q2 2025 · Jun 30, 2024 −$49.92M
Net Income Q2 2025 · Mar 31, 2024 −$25.28M
Operating Income Q2 2025 · Jun 30, 2025 −$4.99M
Operating Income Q2 2025 · Jun 30, 2025 −$20.17M
Operating Income Q2 2025 · Jun 30, 2024 −$24.23M
Operating Income Q2 2025 · Jun 30, 2024 −$50.7M
Revenue Q2 2025 · Jun 30, 2025 $127.79M
Revenue Q2 2025 · Jun 30, 2025 $239.37M
Revenue Q2 2025 · Jun 30, 2024 $77.88M
Revenue Q2 2025 · Jun 30, 2024 $147.1M